The safety and efficacy of Mounjaro have not been established in pediatric patients. Currently, Mounjaro is not approved for use in patients younger than 18 years. Clinical trials are ongoing to evaluate its use in patients aged 10 to below 18 years with type 2 diabetes.
Alert: Order your 3-month supply by October 12 to help avoid potential customs delays.
Get Semaglutide for $184 or Ozempic for $329
